EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Alleviation of Neurological Disorders by Targeting Neurodegenerative-Associated Enzymes: Natural and Synthetic Molecules

Alka Ashok Singh iD, Fazlurrahman Khan iD, Minseok Song

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26104707 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alka Ashok Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Biological Products, Enzyme Inhibitors, Nervous System Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 319 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea, funded by the Ministry of Education…, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurological disorders, encompassing neurodegenerative and neuroinflammatory conditions, present significant public health and clinical challenges. Recent research has elucidated the pivotal role of various enzymes in the onset and progression of these disorders. This review explores the therapeutic potential of targeting these enzymes with natural and synthetic molecules. Key enzymes, including acetylcholinesterase, monoamine oxidase, beta-secretase, tau kinases, caspases, and cyclooxygenase-2, are implicated in diseases such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Modulating these enzymes can alleviate symptoms, slow disease progression, or reverse pathological changes. Natural molecules derived from plants, microbes, seaweeds, and animals have long been noted for their therapeutic potential. Their ability to interact with specific enzymes with high specificity and minimal side effects makes them promising candidates for treatment. These natural agents provide a foundation for developing targeted therapies with improved safety profiles. Simultaneously, the development of synthetic chemistry has resulted in molecules designed to inhibit neurodegenerative enzymes with precision. This review examines the progress in creating small molecules, peptides, and enzyme inhibitors through sophisticated drug design techniques. It evaluates the efficacy, safety, and mechanisms of these synthetic agents, highlighting their potential for clinical application. The review offers a comprehensive overview of recent advancements in enzyme-targeted therapies for neurological disorders, covering both natural and synthetic molecules investigated in preclinical and clinical settings. It discusses the mechanisms through which these molecules exert their effects, the challenges faced in their development, and future research directions. By synthesizing current knowledge, this paper aims to illuminate the potential of enzyme-targeted interventions in managing neurological disorders, showcasing both the promise and limitations of these approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesBiological ProductsEnzyme InhibitorsNervous System DiseasesNeuroprotective AgentsHumansAnimals

Stichwörter der Autor:innen

acetylcholinesterasebeta-secretasecaspasescyclooxygenase-2enzyme inhibitionmechanisms of actionmonoamine oxidasenatural moleculesneurodegenerative diseasessynthetic moleculestau kinases

Substanzen

Biological ProductsEnzyme InhibitorsNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea.
  • Ocean and Fisheries Development International Cooperation Institute, Pukyong National University, Busan 48513, Republic of Korea.
  • International Graduate Program of Fisheries Science, Pukyong National University, Busan 48513, Republic of Korea.

ORCID-Profile: Alka Ashok Singh, Fazlurrahman Khan

Förderung

  • This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea, funded by the Ministry of Education…
  • Ministry of Education

Zitieren

APA

Singh, A. A., Khan, F., & Song, M. (2025). Alleviation of Neurological Disorders by Targeting Neurodegenerative-Associated Enzymes: Natural and Synthetic Molecules. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104707

Vancouver

Singh AA, Khan F, Song M. Alleviation of Neurological Disorders by Targeting Neurodegenerative-Associated Enzymes: Natural and Synthetic Molecules. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104707

BibTeX
@article{Singh2025,
  author = {Singh, Alka Ashok and Khan, Fazlurrahman and Song, Minseok},
  title = {Alleviation of Neurological Disorders by Targeting Neurodegenerative-Associated Enzymes: Natural and Synthetic Molecules},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26104707}
}
Kostenlos starten →